Fertility assay

• US 5,219,729 A
• Filed: 02/25/1988
• Issued: 06/15/1993
• Est. Priority Date: 02/25/1988
• Status: Expired due to Fees

• Current Assignee: Serono Laboratories, Inc. (Merck & Co., Inc.)
• Original Assignee: Serono Laboratories, Inc. (Merck & Co., Inc.)
• Inventors: Hodgen, Gary D.
• Primary Examiner(s): Nucker, Christine M.
• Assistant Examiner(s): Preston, D. R.
• Application Number:
  US07/160,165
• Time in Patent Office: 1,937 Days
• Field of Search: 436/503, 436/501, 436/510, 436/814, 435/29, 435/7.21
• US Class Current: 435/7.21
• CPC Class Codes: G01N 33/567 utilising isolate of tissue or organ as binding agent
• CPC Class Codes: Y10S 436/814 Pregnancy

Abstract

A new diagnostic assay of sperm function has been found for infertility treatment and monitoring programs. The hemizona assay (HZA) measures tight binding of human spermatozoa to the human hemizona pellucida.

Claims

1. A diagnostic assay for predicting sperm fertilizing potential which comprises providing 2 to 8 fragments of mammalian zona pellucida of the same oocyte, contacting a first portion of the fragments with the sperm from the same species to be assayed under binding conditions, contacting a second portion of the fragments with sperm from the same species of known fertilizing potential under binding conditions, said first and second portions having functionally equivalent sperm binding activity, and comparing the resulting sperm binding to one portion with the sperm binding to the other portion.

2. The assay of claim 1 wherein the zona pellucida fragments employed are obtained from human ovarian tissue.

3. The assay of claim 2 wherein each zona pellucida fragment is a hemizona.

4. The assay of claim 1 wherein each zona pellucida portion is a hemizona.

5. The assay of claim 4 in which the sperm and hemizona are human.

6. The assay of claim 5 in which sperm which is not firmly bound is separated from the portions after the contacting of the portions with the sperm and before the comparison step.

7. The assay of claim 6 in which the hemizona are co-incubated.

8. The assay of claim 7 in which the hemizona are provided by disecting the oocyte.

9. The assay of claim 1 in which the fragments are provided by disecting the oocyte.

10. A diagnostic assay for predicting sperm fertilizing potential which comprises contacting sperm to be assayed under binding conditions with a first portion of mammalian zona pellucida of an oocyte from the same species, contacting sperm from the same species of known fertilizing potential under binding conditions with a second separate portion of mammalian zona pellucida of the same oocyte, said first and second portions having functionally equivalent sperm binding activity, and comparing the resulting sperm binding to one portion with the sperm binding to the other portion.

11. A test kit for predicting sperm fertilizing potential comprising 2 to 8 separate containers each of the containers containing a one-half to one-eighth fragment of mammalian zona pellucida of the same oocyte, each of the containers containing functionally equivalent sperm binding activity.

12. The test kit of claim 11 wherein the zona pellucida fragments are hemizona.

13. The test kit of claim 12 wherein the hemizona pellucida are human.

14. The test kit of claim 11 in which the zona pellucida fragments are human.

15. The test kit of claim 14 wherein the zona pellucida fragments are hemizona.

16. The test kit of claim 15 in which each container contains a salt solution and the hemizona.

17. The test kit of claim 11 in which each container contains a salt solution and zona pellucida fragment.

18. A test kit for predicting sperm fertilizing potential comprising separate containers each of which contain a different portion of mammalian zona pellucida of the same oocyte, each of the portions having functionally equivalent sperm binding activity.